ALRM Stock Cash Flow Statements

Alarm.com Quarterly Cash Flow Statements Chart

Quarterly

Annual

Stock-Based Compensation

Alarm.com Quarterly Cash Flow Statements Table

Quarterly

Annual

Unit: USD	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30	2023-06-30	2023-03-31	2022-12-31	2022-09-30	2022-06-30	2022-03-31	2021-12-31	2021-09-30	2021-06-30	2021-03-31	2020-12-31	2020-09-30	2020-06-30	2020-03-31	2019-12-31	2019-09-30	2019-06-30	2019-03-31	2018-12-31	2018-09-30	2018-06-30	2018-03-31	2017-12-31	2017-09-30	2017-06-30	2017-03-31	2016-12-31	2016-09-30	2016-06-30	2016-03-31	2015-12-31	2015-09-30

net income	34,217,000	27,712,000	30,133,000	36,456,000	32,520,000	23,404,000	31,171,000	19,351,000	15,611,000	14,207,000	17,790,000	18,110,000	10,828,000	8,903,000	8,841,000	13,294,000	14,490,000	14,550,000	15,639,000	35,825,000	16,625,000	8,571,000	12,834,000	17,690,000	13,796,000	9,010,000	7,928,000	-7,652,000	10,733,000	10,515,000	320,000	15,103,000	9,865,000	3,963,000	2,976,000	2,567,000	1,873,000	2,738,000	2,989,000	3,229,000
adjustments to reconcile net income to net cash flows from operating activities:
benefit from credit losses on accounts receivable	575,000	977,000	420,000	173,000	103,000	254,000		806,000	76,000	540,000			493,000	54,000			118,000	32,000			-920,000	1,885,000
reserve for product returns	686,000	425,000	515,000	650,000	873,000	1,149,000	1,420,000	481,000	1,347,000	1,151,000	1,025,000	2,006,000	917,000	798,000	866,000	499,000	555,000	574,000	304,000	491,000	709,000	291,000	-18,000	-61,000	76,000	-120,000	63,000	36,000			323,000	588,000	590,000	554,000	534,000	529,000	535,000	473,000	411,000	385,000
benefit from credit losses on notes receivable				0	-2,000	3,998,000																-349,000
amortization on patents and tooling	179,000	178,000	190,000	240,000	197,000	220,000	248,000	328,000	321,000	316,000	322,000	336,000	348,000	353,000	293,000	344,000	315,000	288,000	278,000	203,000	202,000	199,000	194,000	172,000	167,000	167,000	199,000	189,000	276,000	236,000
amortization and depreciation	7,534,000	7,024,000	7,102,000	7,612,000	7,080,000	7,337,000	7,943,000	7,948,000	7,860,000	7,673,000	7,747,000	7,587,000	7,775,000	7,761,000	7,386,000	7,467,000	7,477,000	7,385,000	7,497,000	6,878,000	6,723,000	6,422,000	6,301,000	5,467,000	5,138,000	5,228,000	5,567,000	5,891,000	5,238,000	5,025,000	4,953,000	5,071,000	4,846,000	2,864,000	1,627,000	1,659,000	1,613,000	1,591,000	1,438,000	1,504,000
amortization of debt issuance costs	1,504,000	1,498,000	1,500,000	1,485,000	1,021,000	790,000		787,000	786,000	784,000									27,000	27,000	27,000	27,000	27,000	27,000	27,000	27,000	27,000	27,000	27,000	27,000	27,000	23,000	24,000	23,000	24,000	25,000	28,000	26,000	27,000	27,000
amortization of operating leases	3,926,000	3,903,000	3,659,000	3,472,000	2,977,000	2,976,000	2,944,000	2,919,000	2,871,000	2,750,000	2,732,000	2,702,000	2,592,000	2,473,000	2,519,000	2,478,000	2,357,000	2,338,000	2,326,000	2,328,000	2,189,000	2,045,000
deferred income taxes	-6,882,000	-8,791,000	-1,757,000	-7,747,000	-11,549,000	-13,443,000	-5,118,000	-5,742,000	-9,975,000	-26,895,000	-12,473,000	-19,832,000	-12,084,000	-10,650,000	-4,197,000	1,225,000	-3,965,000	-3,178,000	-1,776,000	1,046,000	-3,853,000	1,327,000	1,097,000	2,129,000	-762,000	135,000	-2,374,000	-7,770,000	-1,542,000	204,000	8,848,000	-3,527,000	-1,710,000	-1,123,000	-2,497,000	-1,342,000	-745,000	-253,000	-1,392,000	-35,000
change in fair value of contingent liability	11,000	-301,000	3,000	61,000	13,000	31,000	45,000	-4,000	14,000	13,000									-2,000	-304,000	-1,721,000	-568,000													-4,000	-36,000	-130,000	-60,000	-650,000
stock-based compensation	8,934,000	9,458,000	9,567,000	9,194,000	11,213,000	11,268,000	10,860,000	11,806,000	11,931,000	12,686,000	14,601,000	13,154,000	12,789,000	12,110,000	11,332,000	9,418,000	10,056,000	7,888,000	8,275,000	7,448,000	7,095,000	6,358,000	5,882,000	5,035,000	5,420,000	4,266,000	3,759,000	3,457,000	3,544,000	2,669,000	2,279,000	1,906,000	1,915,000	1,313,000	1,121,000	1,086,000	942,000	852,000	1,149,000	809,000
income from investments in unconsolidated entities	1,141,000	2,313,000
changes in operating assets and liabilities
accounts receivable	-4,709,000	6,283,000	-6,154,000	1,757,000	3,842,000	826,000	-21,584,000	11,631,000	1,260,000	-1,843,000	-6,025,000	-13,351,000	-6,599,000	1,629,000	-15,252,000	1,876,000	-4,880,000	-5,685,000	-2,967,000	-4,582,000	5,515,000	-8,064,000	-6,269,000	-5,077,000	-4,174,000	-6,753,000	5,847,000	-2,995,000	-9,137,000	-3,013,000	-569,000	656,000	-3,578,000	1,580,000	-1,844,000	-1,915,000	-4,610,000	-2,812,000	133,000	1,404,000
inventory	315,000	-1,859,000	-12,637,000	4,711,000	6,102,000	10,382,000	18,211,000	3,273,000	-900,000	377,000	-3,265,000	-3,998,000	-21,884,000	-11,161,000	-18,824,000	2,711,000	-12,383,000	-2,947,000	-3,438,000	9,029,000	-13,565,000	-2,673,000	-8,503,000	2,917,000	1,819,000	-2,724,000	-6,084,000	-2,188,000	-1,828,000	1,287,000	-560,000	-3,354,000	-2,974,000	3,553,000	962,000	-2,052,000	-1,869,000	-1,109,000	3,102,000	-1,308,000
other current and non-current assets	4,036,000	-8,768,000	2,337,000	-5,635,000	1,563,000	-962,000	-7,761,000	5,991,000	1,121,000	-689,000	-1,509,000	-4,958,000	740,000	-3,225,000	-3,544,000	-237,000	-6,397,000	-1,734,000	2,866,000	-2,279,000	2,838,000	-6,108,000	3,926,000	-2,104,000	-2,342,000	-2,367,000
accounts payable and other current liabilities	-26,962,000	-12,749,000
deferred revenue	-283,000	965,000	-452,000	1,104,000	1,695,000	1,327,000	46,000	1,402,000	1,206,000	1,899,000	-103,000	1,127,000	1,622,000	782,000	-1,240,000	1,058,000	1,363,000	1,127,000	-343,000	1,335,000	-565,000	1,604,000	-414,000	-957,000	-556,000	360,000	-698,000	-97,000	-162,000	-545,000	-24,000	2,000	-282,000	-213,000	506,000	-263,000	156,000	237,000	-14,000	744,000
operating lease liabilities	-2,919,000	-3,474,000	-3,296,000	-2,420,000	-3,530,000	-3,221,000	-3,618,000	-3,533,000	-3,434,000	-3,362,000	-3,333,000	-3,290,000	-3,125,000	-2,975,000	-3,064,000	-3,068,000	-2,905,000	-2,772,000	-2,750,000	-2,699,000	-2,469,000	-2,259,000	-7,587,000	-77,000
other liabilities	664,000	-737,000	423,000	511,000	3,783,000	-1,007,000	-293,000	315,000	591,000	-3,511,000	1,469,000	1,005,000	-329,000	-65,000	2,244,000	-626,000	103,000	162,000	-415,000	58,000	-898,000	812,000	215,000	30,000	852,000	-694,000	-317,000	-957,000	-150,000	-334,000	-123,000	-198,000	1,701,000	-1,066,000	1,424,000	224,000	501,000	1,076,000	3,647,000	3,944,000
cash flows from operating activities	22,716,000	24,057,000	56,260,000	77,337,000			39,872,000	62,826,000			34,446,000	10,197,000			19,963,000	37,886,000	24,076,000	21,232,000	35,410,000	18,622,000			23,265,000	980,000			25,732,000	19,774,000	11,684,000	3,520,000	18,642,000	13,809,000	11,767,000	12,969,000	8,694,000	1,325,000	561,000	6,920,000	5,961,000	13,460,000
cash flows used in investing activities:
business acquisition, net of cash acquired	0	-23,412,000					0	0	0	-9,696,000	0																													-217,000
additions to property and equipment	-4,552,000	-6,115,000	-2,268,000	-2,807,000	-1,992,000	-3,066,000	-2,168,000	-1,956,000	-995,000	-2,398,000	-556,000	-1,782,000	-24,131,000	-2,171,000	-2,123,000	-1,558,000	-3,312,000	-4,069,000	-5,464,000	-3,561,000	-3,397,000	-3,719,000	-8,664,000	-4,952,000	-2,746,000	-2,962,000	-1,698,000	-3,186,000	-3,084,000	-3,047,000	-2,812,000	-1,938,000	-3,077,000	-2,637,000	-2,945,000	-1,546,000	-2,026,000	-2,538,000	-3,827,000	-4,508,000
issuances of notes receivable	-2,000,000	-21,500,000	0	0	0	-500,000	-150,000	0	0	-300,000	0	0														-20,061,000					-3,000,000	-1,000,000	-3,000,000	-1,000,000	-3,000,000	0	0	-73,000	-89,000	-98,000
receipt of payments on notes receivable	20,000	29,000	13,000	12,000	13,000	13,000	15,000	12,000	15,000	13,000	12,000	17,000	16,000	16,000	17,000	37,000	3,000	2,000
capitalized software development costs	-350,000	-408,000	-515,000	-496,000	-224,000	-408,000	-428,000	-200,000	247,000	-362,000
purchase of investments in unconsolidated entities
purchases of other intangible assets				-1,000
cash flows used in investing activities	-177,809,000	-55,179,000	-8,128,000	-7,394,000	-5,198,000	-3,961,000	-4,231,000	-2,144,000	-6,648,000	-12,943,000	-5,694,000	-33,495,000	-26,975,000	-2,155,000			-3,309,000	-9,067,000			-2,293,000	-7,013,000	-67,525,000	12,480,000	4,654,000	-23,023,000	-4,060,000	-3,186,000	-3,084,000	-3,047,000	-5,812,000	1,020,000	-6,077,000	-157,926,000	-5,945,000	-3,146,000	-2,165,000	-170,000	-4,309,000	-4,823,000
cash flows (used in) / from financing activities:
proceeds from issuance of convertible senior notes			0	0											0	0	0	500,000,000
payments of debt issuance costs			0	-888,000											0	0	-407,000	-15,291,000																	0
purchases of capped calls related to convertible senior notes			0	0
payments of deferred consideration for acquisitions			0	-2,700,000			0	-17,000
purchases of treasury stock, including transaction costs	-5,108,000	-5,059,000	0	0			-14,444,000	-6,128,000
payments of tax withholdings related to vesting of restricted stock units			0	0
issuances of common stock from equity-based plans	731,000	1,583,000	2,144,000	1,106,000	378,000	6,356,000	469,000	1,616,000	202,000	1,311,000	629,000	1,728,000	583,000	1,080,000	1,295,000	1,542,000	878,000	1,989,000	5,102,000	2,185,000	3,059,000	1,365,000	566,000									1,602,000	1,078,000	473,000		775,000	56,000	371,000
cash flows (used in) / from financing activities	-6,118,000	-3,476,000									-27,849,000	1,361,000	-27,585,000	-22,251,000																-4,000
effect of exchange rate changes on cash, cash equivalents and restricted cash	-66,000	-118,000	181,000	-157,000	47,000	-180,000	123,000	67,000	-137,000	13,000
net (decrease) / increase in cash, cash equivalents and restricted cash	-161,277,000	-34,716,000									903,000	-21,937,000	-28,341,000	-38,367,000
cash, cash equivalents and restricted cash at beginning of the period	0	1,229,132,000	0	0	0	701,079,000	0	0	0	622,879,000	0	0	0	710,621,000
cash, cash equivalents and restricted cash at end of the period	-161,277,000	1,194,416,000	50,457,000	67,304,000	358,224,000	753,147,000	19,144,000	53,593,000	21,072,000	607,270,000	903,000	-21,937,000	-28,341,000	672,254,000
reconciliation of cash, cash equivalents and restricted cash:
cash and cash equivalents	-161,333,000	1,186,195,000		66,066,000	356,662,000	747,877,000		52,928,000	20,613,000	606,428,000		-22,033,000	-28,373,000	671,753,000
restricted cash included in other current assets and other assets	56,000	8,221,000		1,238,000	1,562,000	5,270,000		665,000	459,000	842,000
total cash, cash equivalents and restricted cash	-161,277,000	1,194,416,000		67,304,000	358,224,000	753,147,000		53,593,000	21,072,000	607,270,000		-21,937,000	-28,341,000	672,254,000
purchase of investment in unconsolidated entities		-3,773,000	-3,973,000	-4,102,000
cash flows from operating activities:
benefit from / (recovery of) credit losses on notes receivable
inventory write-down							239,000	0
gain from investment in unconsolidated entity
accounts payable, accrued expenses and other current liabilities			25,037,000	25,533,000	-34,961,000	4,524,000	4,242,000	5,067,000	4,921,000	-9,617,000	15,135,000	7,757,000	31,496,000	-21,450,000	28,746,000	-2,731,000	13,623,000	-220,000	7,884,000	-11,435,000	17,249,000	83,000	11,979,000	-20,355,000	6,856,000	-9,460,000	2,143,000	27,362,000	8,111,000	-7,001,000	-4,201,000	373,000	7,119,000	483,000	1,156,000	2,034,000	3,607,000	3,661,000	-4,492,000	3,091,000
proceeds from sale of investment											0								0
purchases of intangible assets and other assets
cash flows from / (used in) financing activities:
purchases of redeemable noncontrolling interest							0	0
payments of acquired debt							-24,000	-2,627,000	80,000	-469,000
cash flows from / (used in) financing activities			2,144,000	-2,482,000						842,000																591,000											-77,000	737,000	105,000
net increase / (decrease) in cash, cash equivalents and restricted cash						52,068,000	19,144,000	53,593,000
income from investment in unconsolidated entity				180,000
net increase in cash, cash equivalents and restricted cash				67,304,000
adjustments to reconcile net income to net cash flows from / (used in) operating activities:
cash flows from / (used in) operating activities						49,853,000																12,900,000
purchase of investment in unconsolidated entity							-1,500,000	0	0	-200,000					0	0	0	-5,000,000
cash flows from financing activities:
cash flows from financing activities						6,356,000										1,260,000	-257,000	376,548,000		1,185,000	1,240,000	46,216,000		12,000			146,000	1,696,000			-1,141,000	895,000	76,000	67,473,000
benefit from / (recovery of) credit losses on accounts receivable											-450,000
amortization of debt issuance costs and debt discount
(gain on) / impairment of investment or intangible assets
loss on early extinguishment of debt															0	0	0	185,000
purchases of developed technology and other assets							0	0
repayments of credit facility															0	0	0	-110,000,000	-1,000,000	-1,000,000			-1,000,000	-1,000,000	-1,000,000	-1,000,000	-1,000,000	-1,000,000	-1,000,000	-1,000,000	-73,000,000	-700,000
recovery of credit losses on notes receivable											-1,000	1,000	0	-78,000	1,000	1,000	0	-11,000		14,000
gain on investment												0
cash flows used in financing activities:
cash flows used in financing activities								-7,156,000
adjustments to reconcile net income to net cash flows used in operating activities
cash flows used in operating activities										-3,521,000
purchases of treasury stock											-26,978,000	-367,000	-28,168,000	-23,331,000						0	0	-5,149,000
net decrease in cash, cash equivalents and restricted cash										-15,609,000
benefit from excess and obsolete inventory															74,000				273,000
amortization of debt discount and debt issuance costs											784,000	782,000	780,000	780,000	4,233,000	4,191,000	4,149,000	3,250,000
acquired in-process research and development																			0	0	0	3,297,000	0
gain on sale of investment																			0
purchases of in-process research and development																			0	0	0	-3,297,000	0
purchases of patents, patent licenses and developed technology
proceeds from credit facility																			0	0	0	50,000,000									72,000,000	0	0	67,000,000
payments of deferred consideration for business acquisitions															0	-282,000	-728,000	-150,000	-719,000	0
changes in operating assets and liabilities:
proceeds from investment
restricted cash included in other assets													32,000	501,000
adjustments to reconcile net income to net cash flows (used in) / from operating activities:
cash flows (used in) / from operating activities														-13,961,000												-1,187,000
adjustments to reconcile net income to net cash from operating activities:
(recovery of) / benefit from credit losses on accounts receivable
gain on notes receivable																							0
business acquisitions, net of cash acquired																															0	0	0	-154,289,000
issuances or purchases of notes receivable																			-600,000				-29,000	-6,013,000
net increase / (decrease) in cash and cash equivalents																						52,103,000					21,818,000	18,284,000	9,161,000	469,000							-1,681,000	7,487,000	1,757,000
cash and cash equivalents at beginning of the period															0	0	0	253,459,000	0	0	0	119,629,000	0	0	0	146,061,000	0	0	0	96,329,000	0	0	0	140,634,000	0	0	0	128,358,000	0	0
cash and cash equivalents at end of the period															10,314,000	37,625,000	20,510,000	642,172,000	6,283,000	41,349,000	34,095,000	171,732,000	-44,694,000	13,472,000	28,409,000	122,442,000	21,818,000	18,284,000	9,161,000	96,798,000	11,689,000	15,724,000	5,766,000	63,150,000	5,584,000	886,000	-1,681,000	135,845,000	1,757,000	105,718,000
recovery of credit losses on accounts receivable
cash flows (used in) / from investing activities:
purchases of patents and patent licenses																			-150,000	0
cash flows (used in) / from investing activities
net increase in cash and cash equivalents																37,625,000	20,510,000	388,713,000		41,349,000				13,472,000											5,584,000
(recovery of) / benefit from credit losses on notes receivable
(gain on) / impairment of investment
disposal of property and equipment																											1,125,000	0
purchases of treasury stock and repurchases of common stock
impairment of investment																							0
cash flows from / (used in) investing activities:
receipt of payment on notes receivable																				16,000	2,004,000	3,000	1,000	24,295,000							0
cash flows from / (used in) investing activities
adjustments to reconcile net income to net cash from / (used in) operating activities:
benefit from doubtful accounts																							448,000	262,000	200,000	260,000	41,000	51,000	44,000	13,000	813,000	-380,000	-108,000	128,000	233,000	154,000	106,000	155,000	-144,000	31,000
benefit from notes receivable																							47,000	0
undistributed losses from equity investees																																			21,000	15,000	33,000	12,000	396,000	97,000
investment in cost and equity method investees
repurchases of common stock																											0	0			0	-7,000			1,000	-3,000			0	0
net (decrease) / increase in cash and cash equivalents																										-23,619,000					11,689,000	15,724,000	5,766,000	-77,484,000
amortization of operating lease right-of-use assets																								1,358,000	1,460,000	1,478,000
issuances of common stock from equity based plans																									701,000	1,591,000	1,146,000	2,696,000	1,562,000	996,000									44,000	116,000
adjustments to reconcile net income to net cash (used in) / from operating activities:
other assets																											5,187,000	4,420,000	-3,929,000	-5,563,000	5,580,000	-2,697,000	-6,093,000	668,000	2,219,000	-1,546,000	-1,709,000	199,000	-821,000	-733,000
payments of long-term consideration for business acquisitions																																				-200,000
purchases of licenses to patents																																			0				0	0
proceeds from issuance of common stock from initial public offering, net of underwriting discount and commission																																							0
dividends paid to common stockholders																																							0	0
dividends paid to employees for unvested shares																																							0	0
dividends paid to redeemable convertible preferred stockholders																																							0	0
payments of offering costs																																							0
proceeds from early exercise of stock-based awards																																							5,000	0
amortization for patents and tooling																																243,000	327,000	247,000		186,000
undistributed losses from equity investee																																0
investment in cost method investee																																				0				0
repayments of notes receivable																																			0	0	0	2,441,000
undistributed (gains) / losses from equity investees																																		-5,000
impairment of cost method investment
other																																								27,000
distribution from cost method investee
disposition of marketable securities
proceeds from issuance of debt, net of debt issuance costs
repayments of term loan
payments for long-term business acquisition liabilities
tax windfall benefit from stock-based awards																																							56,000	416,000
proceeds from early exercise of stock options
tax windfall benefit from stock options																																				2,266,000	93,000	366,000
amortization on patents																																						134,000	133,000	134,000
goodwill and intangible asset impairment
gain on release of contingent liability
purchases of marketable securities
unrealized gain on derivative instrument
sale of cost method investee
gain in change in fair value of contingent liability
payments of deferred offering costs
supplemental disclosure of noncash investing and financing activities:
cash not yet paid for business acquisitions
contingent liability from business acquisition
cash not yet paid for capital expenditures
deferred offering costs in accounts payable, accrued expenses and other current liabilities

We provide you with 20 years of cash flow statements for Alarm.com stock, allowing you to gain comprehensive visibility into the fundamentals of the company. Our detailed breakdowns include key financial metrics such as operating cash flows, cash levels, capital expenditures, profits, stock-based compensations and profit margins. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of Alarm.com stock. Explore the full financial landscape of Alarm.com stock with our expertly curated income statements.

The information provided in this report about Alarm.com stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.